ETC
NVO

Exchange Traded Concepts’s Novo Nordisk NVO Stock Holding History

Exchange Traded Concepts’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.01M Sell
146,234
-37,600
-20% -$1.62M 0.03% 425
2026
Q1 		$6.76M Buy
183,834
+12,166
+7% +$576K 0.05% 354
2025
Q4 		$8.73M Buy
171,668
+64,199
+60% +$3.28M 0.07% 293
2025
Q3 		$5.96M Buy
107,469
+19,516
+22% +$1.14M 0.05% 350
2025
Q2 		$6.07M Buy
87,953
+20,084
+30% +$1.37M 0.07% 278
2025
Q1 		$4.71M Sell
67,869
-2,636
-4% -$218K 0.08% 212
2024
Q4 		$6.06M Buy
70,505
+6,543
+10% +$708K 0.12% 185
2024
Q3 		$7.62M Buy
63,962
+18,370
+40% +$2.45M 0.18% 138
2024
Q2 		$6.51M Buy
+45,592
New +$6.04M 0.16% 151

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Exchange Traded Concepts's NVO Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Novo Nordisk (NVO) stake by 20% in Q2 2026, selling an estimated $1.62M and leaving 146,234 shares worth $7.01M. The position accounts for 0.03% of the portfolio, ranked #425.

Exchange Traded Concepts first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.73M in Q4 2025. 344 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Exchange Traded Concepts held 146,234 shares of Novo Nordisk worth $7.01M as of Q2 2026.
  • Exchange Traded Concepts sold 37,600 Novo Nordisk shares in Q2 2026, an estimated $1.62M.
  • Novo Nordisk made up 0.03% of Exchange Traded Concepts's portfolio in Q2 2026, its #425 holding.
  • Exchange Traded Concepts first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Exchange Traded Concepts's Novo Nordisk position peaked at $8.73M in Q4 2025.
  • 344 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.